Atlassian

Atlassian Corp's Cannon-Brookes sells 1415 shares for $98.37 each on 2026-02-05.

Macquarie Lowers Atlassian PT to $150 from $240, Maintains Outperform Rating

Wells Fargo

Wells Fargo Downgrades Atlassian to Overweight with PT Reduced to $155.

Atlassian's Q2 R&D Spend Surges to $826 Million, Shares Slide 8%

Atlassian: Oppenheimer Downgrades PT to $150, Maintains Outperform Rating

Catalyst<ul> <li>Most analysts rate TEAM Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Bearish signals are obviously dominant (3 bearish vs 1 bullish) according to technical analysis.</li> <li>Fund flow trends show negative net inflows for Small, Medium, and Large orders, indicating reduced demand from smaller and mid-sized investors.</li></ul>

Key Factors

Atlassian (TEAM) reported fiscal Q2 revenue of $1.59 billion, exceeding estimates by 31%, with cloud revenue reaching $1.07 billion, up 26% YoY. CEO Michael Cannon-Brookes sold 5,396 shares of TEAM between Feb 3-6, 2026, in multiple transactions at prices ranging from $93.1 to $106.04. Macquarie and several other analysts lowered TEAM's price targets, with Macquarie reducing its PT to $150 from $240 while maintaining an Outperform rating.

TEAM News